Evidence map›Paper›PMID 30009133›Full record

ArticleUrology case reports2018

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase.

Yuji Hakozaki, Taro Murata, Munehiro Yokoyama, Hisashi Matsushima, Maki Ogawa, Tomoko Masuda, Yoko Hirai, Haruki Kume

Open access · goldAbstract readCase Reports
In one paragraph

Article in Urology case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuji HakozakiDepartment of Urology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Taro MurataDepartment of Urology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Munehiro YokoyamaDepartment of Pathology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Hisashi MatsushimaDepartment of Urology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Maki OgawaDepartment of Pathology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Tomoko MasudaDepartment of Urology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Yoko HiraiDepartment of Urology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
Haruki KumeDepartment of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Tokyo Metropolitan Police Hospital · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case with prostate cancer and gastric neuroendocrine carcinoma. A 72-year old male presented with a gastric lesion 5 months after radical prostatectomy. The lesion was immunohistochemically positive for PSA, alpha-methylacyl-CoA racemase, synaptophysin, and chromogranin A, but negative for androgen receptor (AR). Differentiating gastric neuroendocrine carcinoma from gastric metastasis of prostate cancer is difficult, as both lesions exhibit similar acinar cell proliferation with prominent nucleoli.

Indexed as

AMACR, alpha-methylacyl-CoA racemaseAR, androgen receptorCT, computed tomographyGastric neuroendocrine carcinomaImmunohistochemistryProstate cancerPSA, prostate specific antigen

Identifiers

PMID30009133
PMCPMC6043815
OpenAlexW2851124775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.